Clinical evidence and not microbiota outcomes drive value of probiotics

Categorised in: Posted on Wed 29th January

The International Scientific Association of Probiotics and Prebiotics (ISAPP), immediately reacted to the recent papers by Zmora, et al and Suez, et al, with scientific arguments to counter the inaccurate information on probiotics: Hundreds of human trials have demonstrated clinical benefits of probiotics and several evidence-based recommendations have been issued by medical organizations. This irresponsible reporting may lead people who are benefitting from probiotics to stop using them, potentially causing real harm.

Read the ISAPP Response